{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:29:02Z","timestamp":1706747342808},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,1,2]],"date-time":"2024-01-02T00:00:00Z","timestamp":1704153600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,1,2]],"date-time":"2024-01-02T00:00:00Z","timestamp":1704153600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Innere Medizin"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1007\/s00108-023-01637-4","type":"journal-article","created":{"date-parts":[[2024,1,2]],"date-time":"2024-01-02T17:32:28Z","timestamp":1704216748000},"page":"122-128","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Panarteriitis nodosa und Kawasaki-Syndrom","Polyarteritis nodosa and Kawasaki syndrome"],"prefix":"10.1007","volume":"65","author":[{"given":"Ulrike","family":"Sixdorf","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabeth","family":"M\u00e4rker-Hermann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,1,2]]},"reference":[{"key":"1637_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/art.37715","volume":"65","author":"JC Jennette","year":"2013","unstructured":"Jennette\u00a0JC, Falk\u00a0RJ, Bacon\u00a0PA, Basu\u00a0N, Cid\u00a0MC, Ferrario\u00a0F et\u00a0al (2013) 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheumatol 65:1\u201311","journal-title":"Arthritis Rheumatol"},{"key":"1637_CR2","first-page":"484","volume":"1","author":"A Kussmaul","year":"1866","unstructured":"Kussmaul\u00a0A, Maier\u00a0R (1866) \u00dcber eine bisher nicht beschriebene eigenth\u00fcmliche Arterienerkrankung (Periarteriitis nodosa), die mit Morbus Brightii und rapid fortschreitender allgemeiner Muskell\u00e4hmung einhergeht. Dtsch Arch Klin Med 1:484\u2013517","journal-title":"Dtsch Arch Klin Med"},{"issue":"Suppl 111","key":"1637_CR3","first-page":"135","volume":"36","author":"O Karadag","year":"2018","unstructured":"Karadag\u00a0O, Jayne\u00a0DJ (2018) Polyarteritis nodosa revisited: a\u00a0review of historical approaches, subphenotypes and a\u00a0research agenda. Clin Exp Rheumatol 36(Suppl 111):135\u2013142","journal-title":"Clin Exp Rheumatol"},{"key":"1637_CR4","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1007\/s11926-022-01086-2","volume":"24","author":"L Seitz","year":"2022","unstructured":"Seitz\u00a0L, Seitz\u00a0P, Pop\u00a0R, L\u00f6tscher\u00a0F (2022) Spectrum of large and medium vessel Vasculitis in adults: primary vasculitides, arthritides, connective tissue, and fibroinflammatory diseases. Curr Rheumatol Rep 24:352\u2013370","journal-title":"Curr Rheumatol Rep"},{"issue":"sup1","key":"1637_CR5","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1080\/00325481.2022.2088940","volume":"135","author":"JM Springer","year":"2023","unstructured":"Springer\u00a0JM, Byram\u00a0K (2023) Polyarteritis nodosa: an evolving primary systemic vasculitis. Postgrad Med 135(sup1):61\u201368","journal-title":"Postgrad Med"},{"key":"1637_CR6","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1002\/1529-0131(200002)43:2<414::AID-ANR23>3.0.CO;2-0","volume":"43","author":"RA Watts","year":"2000","unstructured":"Watts\u00a0RA, Lane\u00a0SE, Bentham\u00a0G, Scott\u00a0DG (2000) Epidemiology of systemic vasculitis: a\u00a0ten-year study in the United Kingdom. Arthritis Rheum 43:414\u2013419","journal-title":"Arthritis Rheum"},{"key":"1637_CR7","first-page":"1329","volume":"46","author":"AJ Mohammad","year":"2007","unstructured":"Mohammad\u00a0AJ, Jacobsson\u00a0LTH, Mahr\u00a0AD et\u00a0al (2007) Prevalence of Wegener\u2019s granulomatosis, microscopic polyangiitis, polyarteritis nodosa and Churg-Strauss syndrome within a\u00a0defined population in southern Sweden. Baillieres Clin Rheumatol 46:1329\u20131337","journal-title":"Baillieres Clin Rheumatol"},{"key":"1637_CR8","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1097\/00005792-199509000-00002","volume":"74","author":"L Guillevin","year":"1995","unstructured":"Guillevin\u00a0L, Lhote\u00a0F, Cohen\u00a0P et\u00a0al (1995) Polyarteritis nodosa related to hepatitis\u00a0B virus. A\u00a0prospective study with long-term observation of 41\u00a0patients. Med (Baltimore) 74:238\u2013253","journal-title":"Med (Baltimore)"},{"key":"1637_CR9","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1111\/j.1365-4632.2010.04522.x","volume":"49","author":"AJ Morgan","year":"2010","unstructured":"Morgan\u00a0AJ, Schwartz\u00a0RA (2010) Cutaneous polyarteritis nodosa: a\u00a0comprehensive review. Int J Dermatol 49:750\u2013756","journal-title":"Int J Dermatol"},{"key":"1637_CR10","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1097\/MD.0b013e318205a4c6","volume":"90","author":"L Guillevin","year":"2011","unstructured":"Guillevin\u00a0L, Pagnoux\u00a0C, Seror\u00a0R, -for the French Vasculitis Study Group (FVSG), - (2011) The five-factor score revisited: assessment of prognoses of systemic Necrotizing Vasculitides based on the French Vasculitis Study Group (FVSG) cohort. Medicine 90:19\u201327","journal-title":"Medicine"},{"key":"1637_CR11","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1002\/art.27340","volume":"62","author":"C Ribi","year":"2010","unstructured":"Ribi\u00a0C, Cohen\u00a0P, Pagnoux\u00a0C et\u00a0al (2010) Treatment of polyarteritis nodosa and microscopic polyangiitis without poor-prognosis factors: a\u00a0prospective randomized study of one hundred twenty-four patients. Arthritis Rheum 62:1186\u20131197","journal-title":"Arthritis Rheum"},{"key":"1637_CR12","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1002\/1529-0131(200103)44:3<666::AID-ANR116>3.0.CO;2-A","volume":"44","author":"M Gayraud","year":"2001","unstructured":"Gayraud\u00a0M, Guillevin\u00a0L, Toumelin\u00a0P et\u00a0al (2001) Long-term followup of polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome: analysis of four prospective trials including 278 patients. Arthritis Rheum 44:666\u2013675","journal-title":"Arthritis Rheum"},{"issue":"73","key":"1637_CR13","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1002\/art.41776","volume":"2021","author":"SA Chung","year":"2021","unstructured":"Chung\u00a0SA, Gorelik\u00a0M, Langford\u00a0CA et\u00a0al (2021) American college of rheumatology\/Vasculitis foundation guideline for the management of Polyarteritis Nodosa. Arthritis Rheumatol 2021(73):1384","journal-title":"Arthritis Rheumatol"},{"key":"1637_CR14","unstructured":"Neudorf U, Jakob A, Lilienthal E, Hospach T (2020) Leitlinie Kawasaki Syndrom (S2k Leitlinie). AWMF-Registernummer 185-003. https:\/\/www.awmf.org\/uploads\/tx_szleitlinien\/185-003l_S2k_Kawasaki-Syndrom_2021-01.pdf"},{"key":"1637_CR15","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.ijcard.2015.07.063","volume":"201","author":"F Numano","year":"2015","unstructured":"Numano\u00a0F, Shimizu\u00a0C, Jimenez-Fernandez\u00a0S et\u00a0al (2015) Galectin\u20113 is a\u00a0marker of myocardial and vascular fibrosis in Kawasaki disease patients with giant aneurysms. Int J Cardiol 201:429\u2013437","journal-title":"Int J Cardiol"},{"key":"1637_CR16","first-page":"60","volume":"34","author":"R Schmid","year":"2022","unstructured":"Schmid\u00a0R (2022) Wir sehen heute bei Omikron praktisch keine PIMS-F\u00e4lle mehr. P\u00e4diatrie 34:60\u201361","journal-title":"P\u00e4diatrie"},{"key":"1637_CR17","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1097\/INF.0000000000000953","volume":"35","author":"A Jakob","year":"2016","unstructured":"Jakob\u00a0A, Whelan\u00a0J, Kordecki\u00a0M et\u00a0al (2016) Kawasaki Disease in Germany\u2014a prospective, population-based study adjusted for underreporting. Pediatr Infect Dis\u00a0J 35:129\u2013134","journal-title":"Pediatr Infect Dis J"},{"key":"1637_CR18","doi-asserted-by":"publisher","first-page":"e927","DOI":"10.1161\/CIR.0000000000000484","volume":"135","author":"BW McCrindle","year":"2017","unstructured":"McCrindle\u00a0BW, Rowley\u00a0AH, Newburger\u00a0JW, American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee of the Council on Cardiovascular Disease in the Young, Council on Cardiovascular and Stroke Nursing, Council on Cardiovascular Surgery and Anesthesia, Council on Epidemiology and Prevention, - (2017) Diagnosis, treatment, and long-term management of Kawasaki disease: a\u00a0scientific statement for health professionals from the American Heart Association. Circulation 135:e927\u2013e999","journal-title":"Circulation"},{"key":"1637_CR19","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.autrev.2015.11.010","volume":"15","author":"J-B Fraison","year":"2016","unstructured":"Fraison\u00a0J\u2011B, S\u00e8ve\u00a0P, Dauphin\u00a0C et\u00a0al (2016) Kawasaki disease in adults: Observations in France and literature review. Autoimmun Rev 15:242\u2013249","journal-title":"Autoimmun Rev"},{"key":"1637_CR20","doi-asserted-by":"publisher","first-page":"3481","DOI":"10.4049\/jimmunol.1600388","volume":"197","author":"MP Alphonse","year":"2016","unstructured":"Alphonse\u00a0MP (2016) Inositol-Triphosphate 3\u2011Kinase C mediates Inflammasome activation and treatment response in Kawasaki Disease. J\u00a0Immunol 197:3481\u20133489","journal-title":"J Immunol"},{"key":"1637_CR21","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1007\/s00112-022-01490-z","volume":"170","author":"T Hospach","year":"2022","unstructured":"Hospach\u00a0T, Neudorf\u00a0U, Lilienthal\u00a0E et\u00a0al (2022) Aktualisierte Handlungsempfehlung nach der S2k-Leitlinie Kawasaki-Syndrom. Monatsschr Kinderheilkd 170:1122\u20131124","journal-title":"Monatsschr Kinderheilkd"},{"key":"1637_CR22","first-page":"488","volume":"10","author":"J-P Haas","year":"2020","unstructured":"Haas\u00a0J\u2011P, Hospach\u00a0T (2020) Kawasaki-Syndrom. Bayer \u00c4rzteblatt 10:488\u2013491","journal-title":"Bayer \u00c4rzteblatt"},{"key":"1637_CR23","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1007\/s00608-018-0565-6","volume":"53","author":"U Neudorf","year":"2018","unstructured":"Neudorf\u00a0U (2018) Kawasaki Disease: Pathogenesis, Diagnosis and Therapy. Paediatr Paedolog Austria 53:112\u2013116","journal-title":"Paediatr Paedolog Austria"}],"container-title":["Die Innere Medizin"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-023-01637-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00108-023-01637-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-023-01637-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,31]],"date-time":"2024-01-31T12:03:31Z","timestamp":1706702611000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00108-023-01637-4"}},"subtitle":["Vaskulitiden vorwiegend mittelgro\u00dfer und kleiner Gef\u00e4\u00dfe","Vasculitis predominantly of medium size and small vessels"],"short-title":[],"issued":{"date-parts":[[2024,1,2]]},"references-count":23,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["1637"],"URL":"https:\/\/doi.org\/10.1007\/s00108-023-01637-4","relation":{},"ISSN":["2731-7080","2731-7099"],"issn-type":[{"value":"2731-7080","type":"print"},{"value":"2731-7099","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,2]]},"assertion":[{"value":"23 November 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"U.\u00a0Sixdorf und E.\u00a0M\u00e4rker-Hermann geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autorinnen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}